[Volumetric MRI for evaluation of regional pattern and progressin of neocortical degeneration in Alzheimer's disease]
- PMID: 12955216
- DOI: 10.1007/s00117-003-0928-1
[Volumetric MRI for evaluation of regional pattern and progressin of neocortical degeneration in Alzheimer's disease]
Abstract
Purpose: Volumetric analysis of the corpus callosum and hippocampus using MRI in Alzheimer's disease (AD) to evaluate the regional pattern and progression of neocortical neurodegeneration.
Methods: In subsequent studies we investigated patients with AD and healthy controls. Volumetry was based on MRI-data from a sagittal 3D T1w-gradient echo sequence. The corpus callosum (CC) was measured in a midsagittal slice, and subdivided into 5 subregions. Volumetry of the hippocampus/amygdala-formation (HAF) was performed by segmentation in coronary reoriented slices.
Results: In AD patients we found a significant atrophy in the rostrum und splenium of CC. The atrophy was correlated with the severity of dementia, but no correlation was found with the load of white matter lesions. In comparison with (18)FDG-PET, we found a significant correlation of regional CC-atrophy with the regional decline of cortical glucose metabolism. A ROC-analysis demonstrated no significant differences in the diagnostic accuracy of HAF volumetry and regional CC volumetry of the splenium (region C5) even in mild stages of dementia.
Conclusion: Regional atrophy of CC can be used as a marker of neocortical degeneration even in early stages of dementia in AD.
Similar articles
-
In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET.J Neural Transm (Vienna). 2002 May;109(5-6):837-55. doi: 10.1007/s007020200069. J Neural Transm (Vienna). 2002. PMID: 12111472
-
Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration.Neurobiol Aging. 2003 Jan-Feb;24(1):85-94. doi: 10.1016/s0197-4580(02)00044-1. Neurobiol Aging. 2003. PMID: 12493554
-
Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease.Arch Neurol. 1999 Apr;56(4):467-73. doi: 10.1001/archneur.56.4.467. Arch Neurol. 1999. PMID: 10199337
-
Magnetic resonance analysis of amygdalar volume in Alzheimer's disease.Curr Opin Psychiatry. 2007 May;20(3):273-7. doi: 10.1097/YCO.0b013e3280ebb613. Curr Opin Psychiatry. 2007. PMID: 17415082 Review.
-
Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis.Arch Neurol. 1998 Feb;55(2):193-8. doi: 10.1001/archneur.55.2.193. Arch Neurol. 1998. PMID: 9482361 Review.
Cited by
-
Dementia in Down's syndrome: an MRI comparison with Alzheimer's disease in the general population.J Neurodev Disord. 2013 Aug 20;5(1):19. doi: 10.1186/1866-1955-5-19. J Neurodev Disord. 2013. PMID: 23962297 Free PMC article.
-
Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.Brain. 2008 Sep;131(Pt 9):2443-54. doi: 10.1093/brain/awn146. Epub 2008 Jul 11. Brain. 2008. PMID: 18669512 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous